[1]JR JJ.Fatembolism, intravaseularcoagulation, andosteonecrosis. ClinOrthopRelat Res.1993;18(292): 294-308.[2]Li J,Fan L,Yu Z,etal.The effect of deferoxamineon angiogenesis and bone repair in steroid-inducedosteonecrosis of rabbit femoral heads.Exp Biol Med.2015;240(2) :273-280.[3]Harlev D,Zaidman I,Sarig G,et al. Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginasetreatment. Thromb Res.2010;126(2):93-97.[4]Murakawa M, Okamura T, Shibuya T, et al.Use of asyn-thetic protease inhibitor for the treatment of L-asparaginase induced acute pancreatitis complicated by disseminated intravascular coagulation.Ann Hematol. 1992 ;64(5):249-252.[5]Yang L, Boyd K, Kaste SC,et al. A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday. J Orthop Res.2009; 27(2):169-175. [6]Hofbauer LC, Neubauer A ,Heufelder AE.Receptor activator of nuclear factor-kappa B ligand and osteoprotegerin: Potential implications for the pathogenesis and treatment of malignant bone diseases. Cancer.2001;92(3):460-470.[7]Singh PP, van der Kraan AG, Xu Jet al. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. BiochemBiophys Res Commun.2012;422(1):48-53.[8]Boyce BF, Xing L.Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008; 473(2):139-146.[9]Theoleyre S,Wittrant Y,Tat SK,et al.The molecular triad OPG/RANK/RANKL: Involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004;15(6): 457-475.[10]Kawedia JD, Janke L, Funk AJ, et al. Substrain-specific differences in survival and osteonecrosis incidence in a mouse model. Comparative medicine. 2012; 62(6):466-471.[11]Zeng X, Zhan K, Zhang L, et al. The impact of high total cholesterol and high low-density lipoprotein on avascular necrosis of the femoral head in low-energy femoral neck fractures.J OrthopSurg Res.2017;12(1):30.[12]Zheng L, Wang W, Ni J, et al. The association of e NOS gene polymorphism with avascular necrosis of femoral head. PloS one.2014;9(2): e87583. [13]孟晨阳,刘万林,白锐,等.激素性股骨头缺血性坏死发病机制中的细胞自噬[J].中国组织工程研究,2017,21(8):1280-1287.[14]刘彬,李刚,许波, 等.激素性股骨头坏死成脂分化学说及治疗现状[J].中国组织工程研究,2014,18(29):4730-4735.[15]Beckmann R, Shaheen H, Kweider N, et al.Enoxaparin prevents steroid-related avascular necrosisof the femoral head .Scientifc World Journal.2014;2014:347813.[16]Ichiseki T, Kaneuji A, Ueda Y,et al.Osteonecrosis development in a novel rat model characterized bya single application of oxidative stres.Arthritis Rheum.2011;63(7) : 2138-2141.[17]Boquete-Castro A, Gómez-Moreno G, Calvo-Guirado JL, et al.Denosumab and osteonecrosisof the jaw.A systematic analysis of events reported inclinical trials .Clin Oral Implants Res.2016;27(3) :367-375.[18]Couturier MA, Huguet F, Chevallier P, et al.Cerebral venous thrombosis inadult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase:The GRAALL experience. Am J Hematol. 2015;90(11):986-991.[19]Murakawa M, Okamura T, Shibuya T,et al.Use of asyn-thetic protease inhibitor for the treatment of L-asparaginaseinduced acute pancreatitis complicated by disseminated intravascular coagulation. Ann Hematol.1992;64(5):249-252.[20]Qiang H, Liu H, Ling M,et al.Early steroid-inducedosteonecrosis of rabbit femoral head and panaxnotoginsengsaponins:mechanism and protective efects .Evid Based Complement Alternat Med.2015(1):1-10.[21]Rupp RE, Rupp SN.Femoral head avascular necrosis isnot caused by arthroscopic posterolateralfemoroplasty. Orthopedics.2016;39(3):177-180.[22]Jiang Y, Zhang Y, Chen W, et al.Achyranthesbidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. J Transl Med. 2014;12:334.[23]Teitelbaum SL.Bone resorption by osteoclasts. Science.289: 1504-1508, 2000.[24]Yamada Y, Ando F, Niino N.Association ofpolymorphisms of the osteoprotegerin gene with bone mineraldensity in Japanese women but not men. Mol Genet Metab. 2003; 80:344-349.[25]Gori F,Hofbauer LC,Dunstan CR,et al.The expression of osteoprotegerin and RANK ligandand the support of osteoclast formation by stromal-osteoblastlineage cells is developmentally regulated. Endocrinology. 2000;141: 4768-4776. |